Lumida
/ATAI
⌘K
ATAI Life Sciences NV

ATAI Life Sciences NV

ATAI
$7.22USD+0.98%+0.07 today

MARKET CAP

2.7B

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $7

52W RANGE

$3
$7

AI Summary

Stalk
Buy NowMedium

ATAI is in a Stage 2 advancing structure with rising EMAs and a clear HH/HL sequence. An active Lockout Rally—driven by short covering and minimal pullbacks—overrides typical overbought constraints, enforcing bullish execution readiness. Price is extended above short-term EMAs, confirming strength and forced repricing. Medium-term bias remains bullish, so aggressive participation is warranted now, while monitoring for potential resistance rejection.

  • Cash reserves of $430M extend runway into 2024 for 11 programs
  • Phase IIb dosing for VLS-01 done; topline data due Q4 2026
  • Extremely negative earnings yield and low book-to-price imply overvaluation
Full analysis →